Nuveen’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Nuveen’s Portfolio IBDX Stock Details IBDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$12.9K	Buy	+534	New	+$13.2K	﹤0.01%	4490

Other funds holding IBDX

Capital Investment Advisors Atlanta, Georgia $7.74B AUM 15.52% 1-Year Est. Return

Sigma Investment Counselors Northville, Michigan $2.14B AUM 11.72% 1-Year Est. Return

Klingman & Associates New York $2.41B AUM 15.13% 1-Year Est. Return

Sound View Wealth Advisors Group Savannah, Georgia $1.62B AUM 19.49% 1-Year Est. Return

Seven Springs Wealth Group Brentwood, Tennessee $452M AUM 9.03% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $92B AUM 22.91% 1-Year Est. Return

COWA LLC Tulsa, Oklahoma $410M AUM 17.75% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $106B AUM 21.33% 1-Year Est. Return

MV Capital Management Bethesda, Maryland $1.1B AUM 18.81% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Nuveen's IBDX Position: Q3 2026 in Review

Nuveen opened a new position in iShares iBonds Dec 2032 Term Corporate ETF (IBDX) in Q3 2026: 534 shares worth $12.9K. The stake represents ﹤0.01% of the portfolio and ranks #4490 among its holdings.

163 funds tracked by Wall St. Rank hold IBDX as of Q3 2026.

Nuveen held 534 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $12.9K as of Q3 2026.
iShares iBonds Dec 2032 Term Corporate ETF was a new Nuveen position in Q3 2026.
iShares iBonds Dec 2032 Term Corporate ETF made up ﹤0.01% of Nuveen's portfolio in Q3 2026, its #4490 holding.
163 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.